• About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
Tuesday, January 31, 2023
No Result
View All Result
  • Login
Rajesh Spinal Cord Injury
  • Home
  • Spinal Cord Injury
  • Rehabilitation
    •  Epidural Stimulation
  • Latest SCI News
    More golfers with disability to enter tournaments with World Ranking points

    More golfers with disability to enter tournaments with World Ranking points

    Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits

    Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits

    Snow emergency continues Monday night for Madison

    Snow emergency continues Monday night for Madison

    Equilibre Biopharmaceuticals Announces Positive Topline Results from Phase 2 Clinical Trial of EQU-001 (NCT05063877) for Safety, Tolerability and Preliminary Efficacy as Adjunctive Therapy for Focal Seizures in Adults with Epilepsy

    Equilibre Biopharmaceuticals Announces Positive Topline Results from Phase 2 Clinical Trial of EQU-001 (NCT05063877) for Safety, Tolerability and Preliminary Efficacy as Adjunctive Therapy for Focal Seizures in Adults with Epilepsy

    New trial uses cannabis for spinal cord injury induced chronic pain

    New trial uses cannabis for spinal cord injury induced chronic pain

    Kathryn A. Gove | Obituaries | beloitdailynews.com – Beloit Daily News

    Kathryn A. Gove | Obituaries | beloitdailynews.com – Beloit Daily News

    Woman says she’s forced to put cat down her jumper to stay warm amid cost of living crisis

    Woman says she’s forced to put cat down her jumper to stay warm amid cost of living crisis

    Study find out the potential cause of dementia

    Study find out the potential cause of dementia

    Cruel boyfriend who taunted his ex ‘haha I’ve won’ after he left her paralyzed in crash is jailed

    Cruel boyfriend who taunted his ex ‘haha I’ve won’ after he left her paralyzed in crash is jailed

  • Spine
    Global Spine Surgery Devices Market is expected to grow at a decent rate of ~5 % by 2027

    Global Spine Surgery Devices Market is expected to grow at a decent rate of ~5 % by 2027

    ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®

    ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®

    Amplify Surgical®, Inc. Hosts 2nd Annual Endoscopic Spine Symposium with Cadaver Workshop – featuring dualPortal™ Endoscopic and dualX® Systems

    Amplify Surgical®, Inc. Hosts 2nd Annual Endoscopic Spine Symposium with Cadaver Workshop – featuring dualPortal™ Endoscopic and dualX® Systems

    Orthofix Announces Full Commercial Launch and First Patient Cases of Mariner Deformity System

    Orthofix Announces Full Commercial Launch and First Patient Cases of Mariner Deformity System

    Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

    Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

    Tyber Medical Names James Abraham and Damien Sibilla to Executive Leadership Team

    Tyber Medical Names James Abraham and Damien Sibilla to Executive Leadership Team

    IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31%

    IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31%

    icotec ag Receives FDA Clearance for the Ø 4.5mm VADER® Pedicle Screws

    icotec ag Receives FDA Clearance for the Ø 4.5mm VADER® Pedicle Screws

    DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

    DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

  • Neuro
    SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study

    SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study

    Mainstay Medical announces the release of post-marketing data from the ongoing ReActiv8®-C study in patients with chronic low back pain

    Mainstay Medical announces the release of post-marketing data from the ongoing ReActiv8®-C study in patients with chronic low back pain

    Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery

    Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery

    Dr. Robert E. Ayer Has Been Reviewed And Approved By GA Top Docs For 2022

    Dr. Robert E. Ayer Has Been Reviewed And Approved By GA Top Docs For 2022

    Assure Holdings Performs First Neuromonitoring Case in New Jersey

    Assure Holdings Performs First Neuromonitoring Case in New Jersey

    Spine Nevada and Tahoe Fracture Announce Rebrand, Change Name to Swift Institute

    Spine Nevada and Tahoe Fracture Announce Rebrand, Change Name to Swift Institute

    Checkpoint Surgical launches CHECKPOINT GEMINI™ Bipolar Nerve Stimulator for precise stimulation

    Checkpoint Surgical launches CHECKPOINT GEMINI™ Bipolar Nerve Stimulator for precise stimulation

    Novarad secures a strategic regional network alliance for its augmented reality surgical navigation product

    Novarad secures a strategic regional network alliance for its augmented reality surgical navigation product

    Assure Holdings Corp. Prices $6.2 Million Underwritten Public Offering of Common Stock

    Assure Holdings Further Strengthens Business Development Team with Hiring of Robynn Sweet as Vice President, Strategic Accounts

  • Health
    How you can Childproof Your Residence for Security

    How you can Childproof Your Residence for Security

    Tips on how to Defend Towards Fleas and Ticks Hatching within the Spring

    Tips on how to Defend Towards Fleas and Ticks Hatching within the Spring

    Strive These Natural Formulation to Take away Undesirable Physique Hair

    Strive These Natural Formulation to Take away Undesirable Physique Hair

    Conceal Undereye Circles With These Family Substances

    Conceal Undereye Circles With These Family Substances

    These Meals Might Assist Handle Abdomen Acid and Discomfort

    These Meals Might Assist Handle Abdomen Acid and Discomfort

    Summer season Pores and skin Care Secrets and techniques for a Stunning, Wholesome-Wanting Glow

    Summer season Pores and skin Care Secrets and techniques for a Stunning, Wholesome-Wanting Glow

    Wholesome Vacation Present Concepts to Pamper the Household

    Wholesome Vacation Present Concepts to Pamper the Household

    How Digestive Enzymes Can Support Thanksgiving Digestion

    How Digestive Enzymes Can Support Thanksgiving Digestion

    Strive These 6 Vacation Health Ideas for the Complete Household

    Strive These 6 Vacation Health Ideas for the Complete Household

  • Ayurveda
    Benefits, Uses, Side Effects & More

    Benefits, Uses, Side Effects & More

    Banana Hair Masks: Benefits and Precautions

    Banana Hair Masks: Benefits and Precautions

    प्रेगनेंसी में पेट कब निकलता है?

    प्रेगनेंसी में पेट कब निकलता है?

    प्रेगनेंसी में क्या पढ़ना चाहिए? | Books to Read During Pregnancy in Hindi

    प्रेगनेंसी में क्या पढ़ना चाहिए? | Books to Read During Pregnancy in Hindi

    सफेद पानी आने का रीज़न

    सफेद पानी आने का रीज़न

    Everything That You Need to Know About Vitamin B12 for Hair

    Everything That You Need to Know About Vitamin B12 for Hair

    Benefits, Side Effects & How to Use?

    Benefits, Side Effects & How to Use?

    7 Amazing Benefits of Guava Leaves for Hair That Everyone Should Know About!

    7 Amazing Benefits of Guava Leaves for Hair That Everyone Should Know About!

    Everything You Need To Know About Vitamin C Serum For Oily Skin

    Everything You Need To Know About Vitamin C Serum For Oily Skin

  • More
    • Diet-Nutrition
    • Healthy Recipes
    • Nutrition Supplements
    • Weight Loss
    • Yoga & Meditation
  • Home
  • Spinal Cord Injury
  • Rehabilitation
    •  Epidural Stimulation
  • Latest SCI News
    More golfers with disability to enter tournaments with World Ranking points

    More golfers with disability to enter tournaments with World Ranking points

    Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits

    Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits

    Snow emergency continues Monday night for Madison

    Snow emergency continues Monday night for Madison

    Equilibre Biopharmaceuticals Announces Positive Topline Results from Phase 2 Clinical Trial of EQU-001 (NCT05063877) for Safety, Tolerability and Preliminary Efficacy as Adjunctive Therapy for Focal Seizures in Adults with Epilepsy

    Equilibre Biopharmaceuticals Announces Positive Topline Results from Phase 2 Clinical Trial of EQU-001 (NCT05063877) for Safety, Tolerability and Preliminary Efficacy as Adjunctive Therapy for Focal Seizures in Adults with Epilepsy

    New trial uses cannabis for spinal cord injury induced chronic pain

    New trial uses cannabis for spinal cord injury induced chronic pain

    Kathryn A. Gove | Obituaries | beloitdailynews.com – Beloit Daily News

    Kathryn A. Gove | Obituaries | beloitdailynews.com – Beloit Daily News

    Woman says she’s forced to put cat down her jumper to stay warm amid cost of living crisis

    Woman says she’s forced to put cat down her jumper to stay warm amid cost of living crisis

    Study find out the potential cause of dementia

    Study find out the potential cause of dementia

    Cruel boyfriend who taunted his ex ‘haha I’ve won’ after he left her paralyzed in crash is jailed

    Cruel boyfriend who taunted his ex ‘haha I’ve won’ after he left her paralyzed in crash is jailed

  • Spine
    Global Spine Surgery Devices Market is expected to grow at a decent rate of ~5 % by 2027

    Global Spine Surgery Devices Market is expected to grow at a decent rate of ~5 % by 2027

    ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®

    ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®

    Amplify Surgical®, Inc. Hosts 2nd Annual Endoscopic Spine Symposium with Cadaver Workshop – featuring dualPortal™ Endoscopic and dualX® Systems

    Amplify Surgical®, Inc. Hosts 2nd Annual Endoscopic Spine Symposium with Cadaver Workshop – featuring dualPortal™ Endoscopic and dualX® Systems

    Orthofix Announces Full Commercial Launch and First Patient Cases of Mariner Deformity System

    Orthofix Announces Full Commercial Launch and First Patient Cases of Mariner Deformity System

    Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

    Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization

    Tyber Medical Names James Abraham and Damien Sibilla to Executive Leadership Team

    Tyber Medical Names James Abraham and Damien Sibilla to Executive Leadership Team

    IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31%

    IMPLANET Reports 2022 Annual Revenue of €8.0 Million, up 31%

    icotec ag Receives FDA Clearance for the Ø 4.5mm VADER® Pedicle Screws

    icotec ag Receives FDA Clearance for the Ø 4.5mm VADER® Pedicle Screws

    DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

    DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

  • Neuro
    SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study

    SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study

    Mainstay Medical announces the release of post-marketing data from the ongoing ReActiv8®-C study in patients with chronic low back pain

    Mainstay Medical announces the release of post-marketing data from the ongoing ReActiv8®-C study in patients with chronic low back pain

    Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery

    Relievant Medsystems Announces Updated Policy Statement and Guideline for Basivertebral Nerve Ablation from the International Society for the Advancement of Spine Surgery

    Dr. Robert E. Ayer Has Been Reviewed And Approved By GA Top Docs For 2022

    Dr. Robert E. Ayer Has Been Reviewed And Approved By GA Top Docs For 2022

    Assure Holdings Performs First Neuromonitoring Case in New Jersey

    Assure Holdings Performs First Neuromonitoring Case in New Jersey

    Spine Nevada and Tahoe Fracture Announce Rebrand, Change Name to Swift Institute

    Spine Nevada and Tahoe Fracture Announce Rebrand, Change Name to Swift Institute

    Checkpoint Surgical launches CHECKPOINT GEMINI™ Bipolar Nerve Stimulator for precise stimulation

    Checkpoint Surgical launches CHECKPOINT GEMINI™ Bipolar Nerve Stimulator for precise stimulation

    Novarad secures a strategic regional network alliance for its augmented reality surgical navigation product

    Novarad secures a strategic regional network alliance for its augmented reality surgical navigation product

    Assure Holdings Corp. Prices $6.2 Million Underwritten Public Offering of Common Stock

    Assure Holdings Further Strengthens Business Development Team with Hiring of Robynn Sweet as Vice President, Strategic Accounts

  • Health
    How you can Childproof Your Residence for Security

    How you can Childproof Your Residence for Security

    Tips on how to Defend Towards Fleas and Ticks Hatching within the Spring

    Tips on how to Defend Towards Fleas and Ticks Hatching within the Spring

    Strive These Natural Formulation to Take away Undesirable Physique Hair

    Strive These Natural Formulation to Take away Undesirable Physique Hair

    Conceal Undereye Circles With These Family Substances

    Conceal Undereye Circles With These Family Substances

    These Meals Might Assist Handle Abdomen Acid and Discomfort

    These Meals Might Assist Handle Abdomen Acid and Discomfort

    Summer season Pores and skin Care Secrets and techniques for a Stunning, Wholesome-Wanting Glow

    Summer season Pores and skin Care Secrets and techniques for a Stunning, Wholesome-Wanting Glow

    Wholesome Vacation Present Concepts to Pamper the Household

    Wholesome Vacation Present Concepts to Pamper the Household

    How Digestive Enzymes Can Support Thanksgiving Digestion

    How Digestive Enzymes Can Support Thanksgiving Digestion

    Strive These 6 Vacation Health Ideas for the Complete Household

    Strive These 6 Vacation Health Ideas for the Complete Household

  • Ayurveda
    Benefits, Uses, Side Effects & More

    Benefits, Uses, Side Effects & More

    Banana Hair Masks: Benefits and Precautions

    Banana Hair Masks: Benefits and Precautions

    प्रेगनेंसी में पेट कब निकलता है?

    प्रेगनेंसी में पेट कब निकलता है?

    प्रेगनेंसी में क्या पढ़ना चाहिए? | Books to Read During Pregnancy in Hindi

    प्रेगनेंसी में क्या पढ़ना चाहिए? | Books to Read During Pregnancy in Hindi

    सफेद पानी आने का रीज़न

    सफेद पानी आने का रीज़न

    Everything That You Need to Know About Vitamin B12 for Hair

    Everything That You Need to Know About Vitamin B12 for Hair

    Benefits, Side Effects & How to Use?

    Benefits, Side Effects & How to Use?

    7 Amazing Benefits of Guava Leaves for Hair That Everyone Should Know About!

    7 Amazing Benefits of Guava Leaves for Hair That Everyone Should Know About!

    Everything You Need To Know About Vitamin C Serum For Oily Skin

    Everything You Need To Know About Vitamin C Serum For Oily Skin

  • More
    • Diet-Nutrition
    • Healthy Recipes
    • Nutrition Supplements
    • Weight Loss
    • Yoga & Meditation
HealthNews
No Result
View All Result
Home Spinal Cord Injury News

ATHERSYS : REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE – Form 8-K

admin by admin
August 12, 2022
in Spinal Cord Injury News
0
Kringle Pharma : Research Collaboration with Kyoto University in Biomaterial-assisted Regenerative Medicine using HGF

ATHERSYS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Company Restructuring Underway and MASTERS-2 Medical Trial Prioritized

Convention name begins at 4:30 p.m. Japanese time as we speak

CLEVELAND, Ohio, August 11, 2022 – Athersys, Inc. (NASDAQ: ATHX) introduced as we speak its monetary outcomes for the three and 6 months ended June 30, 2022 and offered a enterprise replace.

Second quarter 2022 Company and Operational Highlights:

Company Restructuring

•Carried out a restructuring of our group with the intention of considerably decreasing bills, conserving money, bettering focus of the Firm’s actions and turning into extra engaging to potential monetary and strategic companions.

◦Discount in workforce of as much as 70% together with adjustments to management staff

◦Lowered dimension of Board of Administrators from ten to 5 members whereas sustaining essential expertise and enhancing effectivity

◦Suspended costly manufacturing and course of growth initiatives

◦Initiated a course of to sublet the Stow, Ohio facility

◦Lowered inside analysis operate to focus sources on MASTERS-2

•Made key govt appointments to pursue Athersys’ new enterprise technique

◦Engaged Ankura Consulting Group LLC and named monetary knowledgeable Kasey Rosado interim Chief Monetary Officer

◦Operations and supply-chain chief Maia Hansen named Chief Working Officer

•Exploring financing choices to allow us to acquire funds to proceed operations and execute reprioritized enterprise technique

Enterprise Improvement Technique

•Participated in a number of investor conferences to construct consciousness, together with:

◦Maxim Group 2022 Digital Progress Convention

◦Locust Stroll Stem Cell Convention

◦Needham Healthcare Convention

◦Financial institution of America Securities 2022 World Healthcare Convention

◦H.C. Wainwright World Healthcare Convention

•Pursuing a enterprise growth technique targeted on securing regional and/or world MultiStem companions, non-dilutive funding and complementary capabilities throughout medical, regulatory, industrial and manufacturing capabilities

◦Introduced an August twenty ninth webinar to offer a complete evaluation of preclinical analysis throughout a number of indications with MultiStem hosted by Dr. Willie Mays, Government Vice President and Head of Regenerative Medication & Neuroscience Applications, and Dr. Sarah Busch, Vice President, Regenerative Medication & Head of Nonclinical Improvement; beforehand printed preclinical information display that MultiStem holds potential in Alzheimer’s illness, a number of sclerosis, epilepsy, Parkinson’s illness, spinal twine harm, hypoxia and ischemia

◦Introduced preclinical analysis by the Armed Forces Radiobiology Analysis Institute, a Division of Protection analysis laboratory underneath the management of the Uniformed Companies College of the Health Sciences, displaying the good thing about MultiStem in an animal mannequin of acute radiation syndrome

1

Second Quarter MultiStem Medical Trial Updates

MASTERS-2 (Section 3 world examine in ischemic stroke)

•Reprioritized MASTERS-2 as growth focus following restructuring

•Elevated enrollment charge, doubling the typical variety of sufferers enrolled per 30 days in 2022 from prior years; enrolled extra topics within the second quarter of 2022 than throughout every other quarter

•Expanded the community of lively trial websites by including 10 new areas, together with key stroke facilities in Germany, the UK, Taiwan and Australia

•Analyzed TREASURE outcomes for potential learn by to MASTERS-2 trial design

TREASURE (Section 2/3 Japan examine in ischemic stroke)

•Trial didn’t attain statistical significance for its major endpoint of Glorious Outcomes at 90-days, but the long-term influence on the standard of life amongst handled sufferers was supported by topline outcomes reported by Healios. The complete information set demonstrated constant enchancment in basically all measured purposeful outcomes over time by one 12 months

•Full outcomes will probably be introduced in a plenary session on the 14th World Stroke Congress in October

MATRICS-1 (Section 2 examine in trauma)

•Collaborating with The College of Texas Health Science Heart at Houston, one of many busiest Stage 1 trauma facilities within the U.S.

•Funding offered by Medical Expertise Enterprise Consortium and Memorial Hermann Basis

•Accomplished enrollment of the primary affected person cohort

•Initiated dosing with product derived from Athersys’ large-scale bioreactors, offering better scalability and effectivity

MACOVIA (Section 2/3 examine in acute respiratory misery syndrome)

•Quick-track designation by the FDA

•Now have information evaluating two totally different dosing ranges of MultiStem produced by a cell manufacturing unit course of. Evaluation of this information will assist inform the design of the subsequent part of the trial

•With the intention to focus sources on MASTERS-2, MACOVIA has been suspended till we obtain extra financing or set up a partnership to maneuver ahead with the subsequent part of the examine.

Administration Commentary

“My first six months at Athersys have definitely been each difficult and productive,” acknowledged Dan Camardo, Chief Government Officer of Athersys. “Whereas the topline information from the TREASURE examine evaluating MultiStem for the remedy of ischemic stroke performed by our accomplice Healios in Japan didn’t attain statistical significance for its major Endpoint of Glorious End result at 90-days, there have been essential and inspiring takeaways from this trial. We’re notably happy that the examine demonstrated enchancment in different pre-specified measures of purposeful outcomes over time, supporting the long-term influence of MultiStem in ischemic stroke sufferers. The TREASURE trial outcomes had been positively endorsed by stroke key opinion leaders providing additional encouragement as we proceed with our personal MASTERS-2 examine.” Camardo continued, “We additionally carried out a restructuring of our group with the intention of considerably decreasing bills, conserving money, bettering focus of the Firm’s actions and making a constructive influence on enrollment progress in our MASTERS-2 examine. We’re assured that the actions taken over the past two months will higher place Athersys in bringing MultiStem to market and turning into a worldwide chief in regenerative medication.”

2

Second Quarter Outcomes

Revenues for the three months ended June 30, 2022 had been $2.3 million in comparison with no revenues for the three months ended June 30, 2021. The revenues within the second quarter of 2022 are related to providers offered to Healios underneath the Framework Settlement. Our collaboration revenues will fluctuate from period-to-period based mostly on the providers offered underneath our association with Healios.

Analysis and growth bills elevated to $20.8 million for the three months ended June 30, 2022 from $17.7 million for the comparable interval in 2021. The $3.1 million enhance is related to an impairment cost of $4.9 million associated to property which are not essential to help future analysis and growth and restructuring prices of $1.5 million. These will increase had been partially offset by decreases in medical trial and manufacturing prices of $2.0 million, inside analysis provides of $0.7 million, consulting charges of $0.4 million and reduces in different analysis growth prices of $0.2 million. Our medical growth, medical manufacturing and manufacturing course of growth bills fluctuate over time based mostly on the timing and stage of medical trials underway, manufacturing campaigns for medical trials and manufacturing course of growth initiatives. These variations in exercise degree may influence our accounts payable, accrued bills, pay as you go bills and deposits balances from interval to interval. Apart from exterior bills for our medical and preclinical applications, we typically don’t monitor our analysis bills by mission; relatively, we monitor such bills by the kind of price incurred. We anticipate our analysis and growth bills to lower in reference to our restructuring plan.

Basic and administrative bills had been $5.2 million for the three months ended June 30, 2022, which was greater than the $4.2 million for the comparable interval in 2021. The rise is primarily associated to restructuring prices of $1.2 million. We anticipate our common and administrative bills to lower in reference to our restructuring plan.

Web loss for the second quarter of 2022 was $23.6 million in comparison with a web lack of $22.6 million within the second quarter of 2021. The distinction primarily outcomes from the above variances.

Through the six months ended June 30, 2022, web money utilized in working actions was $36.6 million in comparison with $37.2 million within the six months ended months June 30, 2021. At June 30, 2022, we had $13.4 million in money and money equivalents, in comparison with $37.4 million at December 31, 2021.

Convention Name

Athersys will host a convention name as we speak at 4:30 p.m. Japanese time to debate these outcomes and reply questions. Stockholders are inspired to pay attention utilizing this Webcast hyperlink. To take part through telephone in the event you intend to ask a query, please pre-register for the convention name utilizing this Name registration hyperlink. Registered stockholders will obtain the toll-free quantity, a direct entry passcode and a registrant ID.

A replay of the occasion will probably be obtainable on the webcast hyperlink at www.athersys.com underneath the buyers’ part roughly two hours after the decision has ended. Stockholders may name in for on-demand listening roughly three hours after the completion of the decision till 11:59 p.m. Japanese time on August 18, 2022, by dialing (888) 330-2506 or (240) 789-2712 and getting into the convention code 70781.

3

About Athersys

Athersys is a biotechnology firm engaged within the discovery and growth of therapeutic product candidates designed to increase and improve the standard of human life. The Firm is growing its MultiStem® cell remedy product, a patented, adult-derived “off-the-shelf” stem cell product, initially for illness indications within the neurological, inflammatory and immune, and different essential care indications and has two ongoing medical trials evaluating this potential regenerative medication product. Athersys has cast strategic partnerships and a broad community of collaborations to additional advance MultiStem cell remedy. Buyers and others ought to be aware that we could put up details about the Firm on our web site at www.athersys.com and/or on our accounts on Twitter, Fb, LinkedIn or different social media platforms. It’s potential that the postings might embody data deemed to be materials data. Subsequently, we encourage buyers, the media and others within the Firm to evaluation the data we put up on our web site at www.athersys.com and on our social media accounts. Comply with Athersys on Twitter at www.twitter.com/athersys. Info that we could put up in regards to the Firm on our web site and/or on our accounts on Twitter, Fb, LinkedIn or different social media platforms could include forward-looking statements inside the that means of the Non-public Securities Litigation Reform Act of 1995 that contain dangers and uncertainties. You shouldn’t place undue reliance on forward-looking statements contained on our web site and/or on our accounts on Twitter, Fb, LinkedIn or different social media platforms, and we undertake no obligation to publicly replace forward-looking statements, whether or not because of new data, future occasions or in any other case.

Ahead-Trying Statements

This press launch accommodates forward-looking statements inside the that means of the Non-public Securities Litigation Reform Act of 1995 that contain dangers and uncertainties. These forward-looking statements relate to, amongst different issues, the anticipated timetable for growth of our product candidates, our development technique, and our future monetary efficiency, together with our operations, financial efficiency, monetary situation, prospects, and different future occasions. We’ve tried to establish forward-looking statements by utilizing such phrases as “anticipates,” “believes,” “can,” “proceed,” “might,” “estimates,” “expects,” “intends,” “could,” “plans,” “potential,” “ought to,” “counsel,” “will,” or different related expressions. These forward-looking statements are solely predictions and are largely based mostly on our present expectations.

As well as, various identified and unknown dangers, uncertainties, and different components might have an effect on the accuracy of those statements. A number of the extra vital identified dangers that we face are the danger that we are going to be unable to boost capital to fund our operations within the close to time period and long run, together with our capability to acquire funding by public or non-public fairness choices, debt financings, collaborations and licensing preparations or different sources, on phrases acceptable to us or in any respect, and to proceed as a going concern and our capability to efficiently resolve the cost points with our major contract producer and acquire entry to our medical product. The next dangers and uncertainties could trigger our precise outcomes, ranges of exercise, efficiency, or achievements to vary materially from any future outcomes, ranges of exercise, efficiency, or achievements expressed or implied by these forward-looking statements: our collaborators’ capability and willingness to proceed to satisfy their obligations underneath the phrases of our collaboration agreements and generate gross sales associated to our applied sciences; the potential of unfavorable outcomes from ongoing and extra medical trials involving MultiStem; the danger that constructive ends in a medical trial might not be replicated in subsequent or confirmatory trials or success in an early stage medical trial might not be predictive of ends in later stage or massive scale medical trials; our capability to regain compliance with the requirement to take care of a minimal closing bid value of $1.00 per share as set forth in Nasdaq Itemizing Rule 5550(a)(2); the timing and nature of outcomes from MultiStem medical trials, together with the MASTERS-2 Section 3 medical trial evaluating the administration of MultiStem for the remedy of ischemic stroke; our capability to fulfill milestones and earn royalties underneath our collaboration agreements, together with the success of our collaboration with Healios; the success of our MACOVIA medical trial evaluating the administration of MultiStem for the remedy of ARDS induced by COVID-19 and different pathogens, and the MATRICS-1 medical trial being performed with The College of Texas Health Science Heart at Houston evaluating the remedy of sufferers with severe traumatic accidents; the supply of product enough to fulfill our medical wants and potential industrial demand following any approval; the potential of delays in, hostile outcomes of, and extreme prices of the event course of; our capability to efficiently provoke and full medical trials of our product candidates; the potential of delays, work stoppages or interruptions in manufacturing by third events or us, reminiscent of resulting from materials provide constraints, contamination, operational restrictions resulting from COVID-19 or different public well being emergencies, labor constraints, regulatory points or different components that might negatively influence our trials and the trials of our collaborators; uncertainty relating to market acceptance of our product candidates and our capability to generate revenues, together with MultiStem cell remedy for neurological, inflammatory and immune, cardiovascular and different essential care indications; adjustments in exterior market components; adjustments in our trade’s general efficiency; adjustments in our

4

enterprise technique; our capability to guard and defend our mental property and associated enterprise operations, together with the profitable prosecution of our patent purposes and enforcement of our patent rights, and function our enterprise in an surroundings of speedy know-how and mental property growth; our potential incapacity to understand commercially helpful discoveries in our collaborations with pharmaceutical and different biotechnology firms; the success of our efforts to enter into new strategic partnerships and advance our applications; our potential incapacity to execute our technique resulting from adjustments in our trade or the financial system typically; adjustments in productiveness and reliability of suppliers; the success of our rivals and the emergence of recent rivals; and the dangers talked about elsewhere in our Annual Report on Kind 10-Okay for the 12 months ended December 31, 2021 underneath Merchandise 1A, “Threat Elements” and our different filings with the SEC. You shouldn’t place undue reliance on forward-looking statements contained on our web site and/or on our accounts on Twitter, Fb, LinkedIn or different social media platforms, and we undertake no obligation to publicly replace forward-looking statements, whether or not because of new data, future occasions or in any other case.

Contacts:

Athersys

Ellen Gurley

Supervisor of Company Communications and Investor Relations

ir@athersys.com

LHA Investor Relations

Tirth T. Patel

212-201-6614

tpatel@lhai.com

(Tables Comply with)

5

Athersys, Inc.

Condensed Consolidated Steadiness Sheets

(In 1000’s)

June 30,
2022
December 31,
2021
(Unaudited) (Be aware)
Belongings
Money and money equivalents $ 13,378 $ 37,407
Accounts receivable from Healios, billed and unbilled 3,594 4,414
Pay as you go bills, deposits and different 5,916 5,711
Working right-of-use property, web 8,448 8,960
Property and tools, web 3,868 3,692
Whole property $ 35,204 $ 60,184
Liabilities and stockholders’ fairness
Accounts payable, accrued bills and different present liabilities $ 31,123 $ 24,391
Deferred income – Healios – 3,340
Working lease liabilities 9,263 9,766
Accounts payable to Healios 1,119 1,119
Advance from Healios 5,199 5,199
Different long-term liabilities 238 –
Whole stockholders’ fairness (11,738) 16,369
Whole liabilities and stockholders’ fairness $ 35,204 $ 60,184

Be aware: The Condensed Consolidated Steadiness Sheet Knowledge has been derived from the audited monetary statements as of that date.

6

Athersys, Inc.

Condensed Consolidated Statements of Operations and Complete Loss

(Unaudited)

(In Hundreds, Besides Per Share Quantities)

Three Months Ended
June 30,
2022 2021
Revenues
Contract income from Healios $ 2,316 $ –
Whole revenues 2,316 –
Prices and bills
Analysis and growth 20,794 17,691
Basic and administrative 5,162 4,158
Depreciation 618 723
Whole prices and bills 26,574 22,572
Loss from operations (24,258) (22,572)
Different earnings (loss), web 610 (27)
Web loss and complete loss $ (23,648) $ (22,599)
Web loss per share, primary and diluted $ (0.09) $ (0.10)
Weighted common shares excellent, primary and diluted 259,570 222,436

7

Share via:

0 Shares
  • Facebook 0
  • Twitter
  • Email
  • Copy Link
  • More
ShareTweetSendShare
Previous Post

The Starting Line | UI grad back to her record-setting ways in wheelchair racing | Columns

Next Post

Dr. Sean McCance, Top NYC Spine Surgeon, Recognized as a 2022 Castle Connolly Top Doctor®

admin

admin

Related Posts

More golfers with disability to enter tournaments with World Ranking points
Spinal Cord Injury News

More golfers with disability to enter tournaments with World Ranking points

January 31, 2023
0
Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits
Spinal Cord Injury News

Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits

January 31, 2023
0
Snow emergency continues Monday night for Madison
Spinal Cord Injury News

Snow emergency continues Monday night for Madison

January 30, 2023
0
Equilibre Biopharmaceuticals Announces Positive Topline Results from Phase 2 Clinical Trial of EQU-001 (NCT05063877) for Safety, Tolerability and Preliminary Efficacy as Adjunctive Therapy for Focal Seizures in Adults with Epilepsy
Spinal Cord Injury News

Equilibre Biopharmaceuticals Announces Positive Topline Results from Phase 2 Clinical Trial of EQU-001 (NCT05063877) for Safety, Tolerability and Preliminary Efficacy as Adjunctive Therapy for Focal Seizures in Adults with Epilepsy

January 30, 2023
0
New trial uses cannabis for spinal cord injury induced chronic pain
Spinal Cord Injury News

New trial uses cannabis for spinal cord injury induced chronic pain

January 30, 2023
0
Kathryn A. Gove | Obituaries | beloitdailynews.com – Beloit Daily News
Spinal Cord Injury News

Kathryn A. Gove | Obituaries | beloitdailynews.com – Beloit Daily News

January 30, 2023
0
Load More
Next Post
Dr. Sean McCance, Top NYC Spine Surgeon, Recognized as a 2022 Castle Connolly Top Doctor®

Dr. Sean McCance, Top NYC Spine Surgeon, Recognized as a 2022 Castle Connolly Top Doctor®

Discussion about this post

Recent News

More golfers with disability to enter tournaments with World Ranking points

More golfers with disability to enter tournaments with World Ranking points

January 31, 2023
Global Spine Surgery Devices Market is expected to grow at a decent rate of ~5 % by 2027

Global Spine Surgery Devices Market is expected to grow at a decent rate of ~5 % by 2027

January 31, 2023
Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits

Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits

January 31, 2023
ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®

ZimVie Announces Over 200,000 Cervical Discs Have Been Replaced with Mobi-C®

January 30, 2023

About


Rajeshspinalinjury.com is the latest “Spinal Cord Injury, Neuro, and Health” NEWS website. We’ll provide you with merely interesting content. 

Categories

  • Ayurveda
  • Diet & Nutrition
  • Health News
  • Healthy Recipes
  • Neuro
  • Nutrition Supplements
  • Spinal Cord Injury News
  • Spine
  • Weight Loss
  • Yoga & Meditation
No Result
View All Result

Recent News

More golfers with disability to enter tournaments with World Ranking points

More golfers with disability to enter tournaments with World Ranking points

January 31, 2023
Global Spine Surgery Devices Market is expected to grow at a decent rate of ~5 % by 2027

Global Spine Surgery Devices Market is expected to grow at a decent rate of ~5 % by 2027

January 31, 2023
  • About Us
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Condition

Rajeshspinalinjury © 2022 || All Right Reserved. Design & Development by Rajesh

No Result
View All Result
  • Home
  • Spinal Cord Injury
  •  Epidural Stimulation
  • Rehabilitation
  • Spinal Cord Injury News
  • Spine
  • Neuro
  • Ayurveda
  • Diet & Nutrition
  • Health News
    • Healthy Recipes
  • Nutrition Supplements
  • Yoga & Meditation
  • Weight Loss
  • Contact Us

Rajeshspinalinjury © 2022 || All Right Reserved. Design & Development by Rajesh

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
  • Facebook
  • Twitter
  • Email
  • Copy Link
  • More Networks
Share via
Facebook
Twitter
LinkedIn
Mix
Email
Print
Copy Link
Powered by Social Snap
Copy link
CopyCopied
Powered by Social Snap